These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 19445980

  • 1. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.
    Slütter B, Plapied L, Fievez V, Sande MA, des Rieux A, Schneider YJ, Van Riet E, Jiskoot W, Préat V.
    J Control Release; 2009 Sep 01; 138(2):113-21. PubMed ID: 19445980
    [Abstract] [Full Text] [Related]

  • 2. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B, Somavarapu S, Li XW, Thanou M, Sesardic D, Alpar HO, Senel S.
    Int J Pharm; 2008 Nov 03; 363(1-2):139-48. PubMed ID: 18662762
    [Abstract] [Full Text] [Related]

  • 3. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
    Slütter B, Bal S, Keijzer C, Mallants R, Hagenaars N, Que I, Kaijzel E, van Eden W, Augustijns P, Löwik C, Bouwstra J, Broere F, Jiskoot W.
    Vaccine; 2010 Aug 31; 28(38):6282-91. PubMed ID: 20638455
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen.
    Slütter B, Soema PC, Ding Z, Verheul R, Hennink W, Jiskoot W.
    J Control Release; 2010 Apr 19; 143(2):207-14. PubMed ID: 20074597
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo study of N-trimethyl chitosan nanoparticles for oral protein delivery.
    Chen F, Zhang ZR, Yuan F, Qin X, Wang M, Huang Y.
    Int J Pharm; 2008 Feb 12; 349(1-2):226-33. PubMed ID: 17825506
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination.
    Verheul RJ, Slütter B, Bal SM, Bouwstra JA, Jiskoot W, Hennink WE.
    J Control Release; 2011 Nov 30; 156(1):46-52. PubMed ID: 21784113
    [Abstract] [Full Text] [Related]

  • 10. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells.
    Han R, Zhu J, Yang X, Xu H.
    J Biomed Mater Res A; 2011 Jan 30; 96(1):142-9. PubMed ID: 21105162
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antigen-conjugated N-trimethylaminoethylmethacrylate chitosan nanoparticles induce strong immune responses after nasal administration.
    Liu Q, Zheng X, Zhang C, Shao X, Zhang X, Zhang Q, Jiang X.
    Pharm Res; 2015 Jan 30; 32(1):22-36. PubMed ID: 24970313
    [Abstract] [Full Text] [Related]

  • 14. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O, Silva M, de Sousa A, Borchard G, Junginger HE, Cordeiro-da-Silva A.
    Int Immunopharmacol; 2008 Dec 20; 8(13-14):1773-80. PubMed ID: 18801462
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives.
    Akagi T, Wang X, Uto T, Baba M, Akashi M.
    Biomaterials; 2007 Aug 20; 28(23):3427-36. PubMed ID: 17482261
    [Abstract] [Full Text] [Related]

  • 17. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery.
    Gordon S, Saupe A, McBurney W, Rades T, Hook S.
    J Pharm Pharmacol; 2008 Dec 20; 60(12):1591-600. PubMed ID: 19000363
    [Abstract] [Full Text] [Related]

  • 18. Modulating dendritic cells to optimize mucosal immunization protocols.
    Williamson E, Westrich GM, Viney JL.
    J Immunol; 1999 Oct 01; 163(7):3668-75. PubMed ID: 10490961
    [Abstract] [Full Text] [Related]

  • 19. Investigation of lectinized liposomes as M-cell targeted carrier-adjuvant for mucosal immunization.
    Gupta PN, Vyas SP.
    Colloids Surf B Biointerfaces; 2011 Jan 01; 82(1):118-25. PubMed ID: 20843665
    [Abstract] [Full Text] [Related]

  • 20. Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice.
    Bal SM, Slütter B, Verheul R, Bouwstra JA, Jiskoot W.
    Eur J Pharm Sci; 2012 Mar 12; 45(4):475-81. PubMed ID: 22009113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.